Cargando…

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy

Detalles Bibliográficos
Autores principales: Jiang, Wei, Wei, Lulu, Chen, Bing, Luo, Xingyu, Xu, Peipei, Cai, Jianfeng, Hu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118707/
https://www.ncbi.nlm.nih.gov/pubmed/35590404
http://dx.doi.org/10.1186/s12951-022-01418-5
_version_ 1784710555545632768
author Jiang, Wei
Wei, Lulu
Chen, Bing
Luo, Xingyu
Xu, Peipei
Cai, Jianfeng
Hu, Yong
author_facet Jiang, Wei
Wei, Lulu
Chen, Bing
Luo, Xingyu
Xu, Peipei
Cai, Jianfeng
Hu, Yong
author_sort Jiang, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-9118707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91187072022-05-20 Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy Jiang, Wei Wei, Lulu Chen, Bing Luo, Xingyu Xu, Peipei Cai, Jianfeng Hu, Yong J Nanobiotechnology Correction BioMed Central 2022-05-19 /pmc/articles/PMC9118707/ /pubmed/35590404 http://dx.doi.org/10.1186/s12951-022-01418-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Jiang, Wei
Wei, Lulu
Chen, Bing
Luo, Xingyu
Xu, Peipei
Cai, Jianfeng
Hu, Yong
Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
title Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
title_full Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
title_fullStr Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
title_full_unstemmed Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
title_short Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
title_sort correction to: platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118707/
https://www.ncbi.nlm.nih.gov/pubmed/35590404
http://dx.doi.org/10.1186/s12951-022-01418-5
work_keys_str_mv AT jiangwei correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy
AT weilulu correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy
AT chenbing correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy
AT luoxingyu correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy
AT xupeipei correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy
AT caijianfeng correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy
AT huyong correctiontoplatinumprodrugnanoparticlesinhibitingtumorrecurrenceandmetastasisbyconcurrentchemoradiotherapy